Porcine Vaccine Global Market Report 2025

Description

Porcine vaccines are medical and pharmaceutical treatments designed to enhance the health of pigs by protecting them from various bacteria, viruses, and infections. These vaccines aim to increase the effectiveness of safeguarding pigs from harmful diseases while also improving the production of high-quality meat for human consumption.

In the realm of porcine vaccines, major technologies include inactivated vaccines, live attenuated vaccines, toxoid vaccines, recombinant vaccines, conjugate vaccines, and DNA vaccines. Inactivated vaccines, for instance, are made from killed or inactivated viruses or bacteria and stimulate an immune response to protect pigs against natural infections. These vaccines are employed to address various diseases such as diarrhea, swine influenza, arthritis, bordatella rhinitis, porcine reproductive and respiratory virus (PRRSV), porcine circovirus-associated disease (PCVAD), and others, commonly utilized in hospitals and pig production farms.

The porcine vaccines market research report is one of a series of new reports from The Business Research Company that provides porcine vaccines market statistics, including porcine vaccines industry global market size, regional shares, competitors with a porcine vaccines market share, detailed porcine vaccines market segments, market trends and opportunities, and any further data you may need to thrive in the porcine vaccines industry. This porcine vaccines market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The porcine vaccine market size has grown strongly in recent years. It will grow from $1.89 billion in 2024 to $2.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to disease outbreaks and control measures, global increase in pork consumption, intensification of pig farming, government initiatives for disease control, awareness and education programs.

The porcine vaccine market size is expected to see strong growth in the next few years. It will grow to $2.96 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to global expansion of pig farming, rising disease challenges, stringent regulations and compliance, technological advancements in vaccine development, global trade and disease risk mitigation. Major trends in the forecast period include customization of vaccines for regional challenges, integration of biotechnology in vaccine development, rising concerns about zoonotic diseases, application of genomic approaches in vaccine design, growing investments in research and development.

The increasing prevalence of swine diseases is expected to drive the growth of the porcine vaccine market. Swine influenza (swine flu) is a respiratory illness commonly affecting pigs, often caused by the type A influenza virus, which can lead to frequent influenza outbreaks in pig populations. Porcine vaccines, when administered to pigs, stimulate their immune systems to recognize and respond to pathogenic agents by inducing an immunogenic reaction. This immune response helps the swine fight off pathogens and prevents disease through an anamnestic reaction when exposed to the same pathogen again. For example, in September 2024, the Government of the United Kingdom reported that an outbreak of African swine fever (ASF) could have severe consequences for the UK's £8 billion pig industry and its £600 million annual pork export sector, with potential financial impacts estimated between £10 million and £100 million. Therefore, the rising incidence of swine diseases is fueling growth in the porcine vaccine market.

The increasing consumption of pork is expected to contribute to the growth of the porcine vaccine market. As the global population grows, there is a rising demand for protein, leading to an increase in pork consumption. To meet this demand efficiently, pig farming has become more intensive, making vaccinations essential for maintaining the health and productivity of pig herds. For instance, in March 2022, Pig333 reported that pork consumption in China was approximately 61, 52, and 37 kg per inhabitant. The projections indicate a 4.1% growth in consumption in China by 2022, reaching almost 52 kg per inhabitant. This upward trend in pork consumption underscores the importance of porcine vaccines in supporting the health and sustainability of pig farming, thereby driving the growth of the porcine vaccine market.

Leading companies in the porcine vaccine market are forming strategic partnerships to boost research and development and enhance their competitiveness in the fast-changing animal health sector. One such collaboration leverages The Vaccine Group's (TVG) vaccine technology expertise and The Pirbright Institute's knowledge of African swine fever (ASF) research to advance the vaccine development process and create innovative solutions for swine health. For instance, in May 2024, The Pirbright Institute, a UK-based research organization, partnered with TVG, a UK-based company, to develop an ASF vaccine using bovine herpesvirus 4 (BoHV-4) as a platform. This approach incorporates the latest advancements in ASF vaccine research and pig immunology to improve vaccine efficacy. The initiative is funded by the U.K. Department for Environment, Food and Rural Affairs (Defra) and the Biotechnology and Biological Sciences Research Council (BBSRC).

The noteworthy development involves major companies in the porcine vaccine market introducing innovative products such as the 3-in-one swine vaccine, offering enhanced protection against various diseases. Merck Animal Health, a US-based pharmaceutical company, launched Circumvent CML in June 2023. This three-in-one vaccine controls Porcine Circovirus Type 2a (PCV-2a), Porcine Circovirus Type 2d (PCV-2d), Mycoplasma hyopneumoniae, and Lawsonia intracellularis. The product provides convenience and assurance to producers and caregivers, simplifying the vaccination process and reducing the number of injections for younger pigs. Built on a foundation of proven adjuvant systems and antigens, Circumvent CML signifies a novel approach in swine vaccination.

In July 2024, Merck Animal Health Inc., a US-based company, acquired Elanco Animal Health Inc. for an undisclosed amount. Through this acquisition, Merck Animal Health aims to broaden its portfolio by integrating Elanco's expertise in porcine vaccines. Elanco Animal Health, also a US-based company, specializes in providing porcine vaccines, supporting the health and immunity of swine populations.

Major companies operating in the porcine vaccine market include Sanofi Pasteur Inc., Boehringer Ingelheim International GmbH, Zoetis Inc., Arko Laboratories Limited, Merck Animal Health, Elanco Animal Health Incorporated, Ceva Sante Animale, Huvepharma Inc., Phibro Animal Health Corporation, Vetoquinol SA, Intervet Inc., HIPRA S.A., Ringpu Bio-Pharmacy Co Ltd., IDT Biologika GmbH, Bimeda Holdings PLC, Jinyu Bio-Technology Co Ltd., Biogenesis Bago, Pharmaq AS, Veterquimica S.A., Kyoto Biken Laboratories Inc., Dopharma Research B.V., Agrovet Market Animal Health Ltd., Innovad SA, PBS Animal Health, Merial Animal Health, Aptimmune Biologics Inc., Syntex SA de CV, Zoovet S.A., Shenzhen Weierkang Xiang Animal Pharm Co Ltd., Wuhan Keqian Biology Co Ltd., Anicon Labor GmbH

North America is the largest region in the porcine vaccine market in 2024. The regions covered in the porcine vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the porcine vaccine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The porcine vaccines market consists of sales of antibacterial vaccines and antiviral vaccines. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Porcine Vaccine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on porcine vaccine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for porcine vaccine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The porcine vaccine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Technology: Inactivated Vaccines; Live Attenuated Vaccines; Toxoid Vaccines; Recombinant Vaccines; Conjugate Vaccines; DNA Vaccines
2) By Disease Indication: Diarrhea; Swine Influenza; Arthritis; Bordetella Rhinitis; Porcine Reproductive and Respiratory Virus (PRRSV); Porcine Circovirus Associated Disease (PCVAD); Other Disease Indications
3) By End User: Veterinary Hospitals; Hog or Pig Production Farm
Subsegments:
1) By Inactivated Vaccines: Whole Virus Inactivated Vaccines; Subunit Inactivated Vaccines
2) By Live Attenuated Vaccines: Live Modified Vaccines; Live Virulent Vaccines
3) By Toxoid Vaccines: Inactivated Toxins
4) By Recombinant Vaccines: Recombinant Vector Vaccines; Subunit Recombinant Vaccines
5) By Conjugate Vaccines: Polysaccharide Conjugate Vaccines
6) By DNA Vaccines: Plasmid DNA Vaccines
Companies Mentioned: Sanofi Pasteur Inc.; Boehringer Ingelheim International GmbH; Zoetis Inc.; Arko Laboratories Limited; Merck Animal Health
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r26889

1. Executive Summary

2. Porcine Vaccine Market Characteristics

3. Porcine Vaccine Market Trends And Strategies

4. Porcine Vaccine Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Porcine Vaccine Growth Analysis And Strategic Analysis Framework

5.1. Global Porcine Vaccine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Porcine Vaccine Market Growth Rate Analysis
5.4. Global Porcine Vaccine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Porcine Vaccine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Porcine Vaccine Total Addressable Market (TAM)

6. Porcine Vaccine Market Segmentation

6.1. Global Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Vaccines
Live Attenuated Vaccines
Toxoid Vaccines
Recombinant Vaccines
Conjugate Vaccines
DNA Vaccines
6.2. Global Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Diarrhea
Swine Influenza
Arthritis
Bordetella Rhinitis
Porcine Reproductive and Respiratory Virus (PRRSV)
Porcine Circovirus Associated Disease (PCVAD)
Other Disease Indications
6.3. Global Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Veterinary Hospitals
Hog or Pig Production Farm
6.4. Global Porcine Vaccine Market, Sub-Segmentation Of Inactivated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Whole Virus Inactivated Vaccines
Subunit Inactivated Vaccines
6.5. Global Porcine Vaccine Market, Sub-Segmentation Of Live Attenuated Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Live Modified Vaccines
Live Virulent Vaccines
6.6. Global Porcine Vaccine Market, Sub-Segmentation Of Toxoid Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Inactivated Toxins
6.7. Global Porcine Vaccine Market, Sub-Segmentation Of Recombinant Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Recombinant Vector Vaccines
Subunit Recombinant Vaccines
6.8. Global Porcine Vaccine Market, Sub-Segmentation Of Conjugate Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polysaccharide Conjugate Vaccines
6.9. Global Porcine Vaccine Market, Sub-Segmentation Of DNA Vaccines, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Plasmid DNA Vaccines

7. Porcine Vaccine Market Regional And Country Analysis

7.1. Global Porcine Vaccine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Porcine Vaccine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Porcine Vaccine Market

8.1. Asia-Pacific Porcine Vaccine Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Porcine Vaccine Market

9.1. China Porcine Vaccine Market Overview
9.2. China Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Porcine Vaccine Market

10.1. India Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Porcine Vaccine Market

11.1. Japan Porcine Vaccine Market Overview
11.2. Japan Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Porcine Vaccine Market

12.1. Australia Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Porcine Vaccine Market

13.1. Indonesia Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Porcine Vaccine Market

14.1. South Korea Porcine Vaccine Market Overview
14.2. South Korea Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Porcine Vaccine Market

15.1. Western Europe Porcine Vaccine Market Overview
15.2. Western Europe Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Porcine Vaccine Market

16.1. UK Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Porcine Vaccine Market

17.1. Germany Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Porcine Vaccine Market

18.1. France Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Porcine Vaccine Market

19.1. Italy Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Porcine Vaccine Market

20.1. Spain Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Porcine Vaccine Market

21.1. Eastern Europe Porcine Vaccine Market Overview
21.2. Eastern Europe Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Porcine Vaccine Market

22.1. Russia Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Porcine Vaccine Market

23.1. North America Porcine Vaccine Market Overview
23.2. North America Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Porcine Vaccine Market

24.1. USA Porcine Vaccine Market Overview
24.2. USA Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Porcine Vaccine Market

25.1. Canada Porcine Vaccine Market Overview
25.2. Canada Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Porcine Vaccine Market

26.1. South America Porcine Vaccine Market Overview
26.2. South America Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Porcine Vaccine Market

27.1. Brazil Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Porcine Vaccine Market

28.1. Middle East Porcine Vaccine Market Overview
28.2. Middle East Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Porcine Vaccine Market

29.1. Africa Porcine Vaccine Market Overview
29.2. Africa Porcine Vaccine Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Porcine Vaccine Market, Segmentation By Disease Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Porcine Vaccine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Porcine Vaccine Market Competitive Landscape And Company Profiles

30.1. Porcine Vaccine Market Competitive Landscape
30.2. Porcine Vaccine Market Company Profiles
- 30.2.1. Sanofi Pasteur Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Zoetis Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. Arko Laboratories Limited Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. Merck Animal Health Overview, Products and Services, Strategy and Financial Analysis

31. Porcine Vaccine Market Other Major And Innovative Companies

31.1. Elanco Animal Health Incorporated
31.2. Ceva Sante Animale
31.3. Huvepharma Inc.
31.4. Phibro Animal Health Corporation
31.5. Vetoquinol SA
31.6. Intervet Inc.
31.7. HIPRA S.A.
31.8. Ringpu Bio-Pharmacy Co Ltd.
31.9. IDT Biologika GmbH
31.10. Bimeda Holdings PLC
31.11. Jinyu Bio-Technology Co Ltd.
31.12. Biogenesis Bago
31.13. Pharmaq AS
31.14. Veterquimica S.A.
31.15. Kyoto Biken Laboratories Inc.

32. Global Porcine Vaccine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Porcine Vaccine Market

34. Recent Developments In The Porcine Vaccine Market

35. Porcine Vaccine Market High Potential Countries, Segments and Strategies

35.1 Porcine Vaccine Market In 2029 - Countries Offering Most New Opportunities
35.2 Porcine Vaccine Market In 2029 - Segments Offering Most New Opportunities
35.3 Porcine Vaccine Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer